The hitchhiker's guide to parenteral nutrition management for adult patients

Practical Gastroenterology

Volumn 30, Issue 7, 2006, Pages 46-68

  Madsen, Howard ^a   Frankel, Erik H ^a  

^a Department of Orthopaedic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMINESS; AMINO ACID; AMINOSYN; ARGININE; BRANCHED CHAIN AMINO ACID; CLINISOL; DRUG ADDITIVE; ESSENTIAL AMINO ACID; FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; FREAMINE; GLUCONATE CALCIUM; GLUCOSE; GLYCERYL TRINITRATE; HEPARIN; HEPATASOL; HISTIDINE; HYDROCORTISONE; INFUSION FLUID; INFUVITE; INSULIN ASPART; INSULIN LISPRO; LIPID EMULSION; LONG CHAIN TRIACYLGLYCEROL; MAGNESIUM SULFATE; MVI ADULT; NEPHRAMINE; NONESSENTIAL AMINO ACID; NOVAMINE; PARENTERAL SOLUTION; POLYSTYRENESULFONATE SODIUM; POTASSIUM CHLORIDE; POTASSIUM DIHYDROGEN PHOSPHATE; PROPOFOL; PROSOL; RENAMINE; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; TRACE ELEMENT; TRAVASOL; TROPHAMINE; UNINDEXED DRUG; WATER;

ANAPHYLAXIS; BLOOD CLOTTING DISORDER; CHOLESTASIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIGESTIVE SYSTEM ULCER; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MONITORING; DRUG SAFETY; DRUG STABILITY; ELECTROLYTE DISTURBANCE; ENTEROPATHY; FATTY LIVER; FEVER; GASTROINTESTINAL DISEASE; HEPATOSPLENOMEGALY; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; INFECTION; IRON DEFICIENCY; METABOLIC BONE DISEASE; MINERAL DEFICIENCY; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; OBESITY; OSMOLARITY; PARENTERAL NUTRITION; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; RISK BENEFIT ANALYSIS; THROMBOPHLEBITIS; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VASCULAR ACCESS; VITAMIN DEFICIENCY;

EID: 33746921282     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Lipman TO. The chicken soup paradigm. J Parenter Enteral Nutr, 2003;27:93-99.
2. Braunschweig CL, Levy P, Sheean PM, et al. Enteral compared with parenteral nutrition: a meta- analysis. Am J Clin Nutr, 2001;74:534-542.
3. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med, 1991;22;325(8):525-532.
4. Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. J Parent Enteral Nutr, 2003;27(5):355-373.
5. American College of Chest Physicians Consensus Statement. Chest, 1997;111(3):769-777.
6. National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition. J Parent Enteral Nutr, 1998;22(2):49-66.
7. Krenitsky J. Adjusted body weight, pro: evidence to support the use of adjusted body weight in calculating calorie requirements. Nutr Clin Pract, 2005;20:468-473.
8. Frankenfield D. Energy and macrosubstrate requirements. In: Gottschlich MM, Ed. The Science and Practice of Nutrition Support: A Case-based Core Curriculum. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:36.
9. Von Allmen D, Fisher JF. Metabolic Complications. In: Fischer JF (ed). Total Parenteral Nutrition. 2nd Ed. Boston, MA: Little Brown Company; 1991.
10. Krzywda EA, Andris DA, Edmiston CE, et al. Parenteral Access Devices. In: Gottschlich MM, Ed. The Science and Practice of Nutrition Support: A Case-Based Core Curriculum. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:230.
11. Jerome L, Cookson ST, McArthur MA, et al. Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Inter Med, 1999;131(5):340-347.
12. Infusion Nurses Society. Infusion Nursing Standards of Practice. J Infusion Nursing, 2006;29(1S):75.
13. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR, 2002;51(RR-10):1-29.
14. Mirtallo JM. Introduction to Parenteral Nutrition. In: Gottschlich MM, Ed. The Science and Practice of Nutrition Support: A Case-Based Core Curriculum. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:217.
15. Adapted from information gathered from calculating osmolarity of an IV admixture viewed 05/31/2006 on http://rxkinetics.com/iv_osmolarity.html
16. Tighe MJ, Wong C, Martin IG, et. al. Do heparin, hydrocortisone, and glyceryl trinitrate influence thrombophlebitis during full intravenous nutrition via a peripheral vein? J Parent Enteral Nutr, 1995;19(6):507-509.
17. Roongpisuthipong C, Puchaiwatananon O, Songchitsomboon S, et al. Hydrocortisone, heparin, and peripheral intravenous infusion. Nutrition, 1994;10(3):211-213.
18. Khawaja HT, Williams JD, Weaver PC. Transdermal glyceryl trinitrate to allow peripheral total parenteral nutrition: a doubleblind placebo controlled feasibility study. J Royal Soc Med, 1991; 84:69-72.
19. Grimm H, Tibell A, Norrlind B, Blecher C, et al. Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. J Parent Enteral Nutr, 1994;18(5):417-421.
20. Haber LM, Hawkins EP, Seilheimer DK, et al. Fat overload syndrome. An autopsy study with evaluation of the coagulopathy. Am J Clin Pathol, 1988;90(2):223-227.
21. Dahlstrom KA, Goulet OJ, Roberts RL, et al. Lipid tolerance in children receiving long-term parenteral nutrition: a biochemical and immunologic study. J Pediatr, 1988;113(6):985-990.
22. Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. J Parent Enteral Nutr, 2004;28(6):S39-S70.
23. Wolfe RR, O'Donnell TF Jr, Stone MD, et al. Investigation of factors determining optimal glucose infusion rate in total parenteral nutrition. Metabolism, 1980;29:892-900.
24. Frankenfield D. Energy and macrosubstrate requirements. In: Gottschlich MM, Ed. The Science and Practice of Nutritional Support: A Case Based Core-Curriculum. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:234.
25. Macias WL, Alaka KJ, Murphy MH, et al. Impact of nutritional regimen on protein catabolism and nitrogen balance in patients with acute renal failure. J Parent Enteral Nutr, 1996;20:56-62.
26. Druml W. Nutritional management of acute renal failure. Am J Kidney Dis, 2001;37(1 Suppl 2):S89-S94.
27. Krenitsky J. Nutrition in Renal Failure: Myths and Management. Pract Gastroenterol, 2004;28(9):40.
28. Krenitsky J. Nutritional Guidelines for Patients with Hepatic Failure. Pract Gastroenterol, 2003;27(6):23.
29. Van Way CW. Total calories vs nonprotein calories. Nutr Clin Pract, 2001;16:271-272.
30. Miles JM, Klein J. Should protein calories be included in caloric calculations for a TPN prescription? Point-counterpoint. Nutr Clin Pract, 1996;11:204-206.
31. Devlin JW, Lau AK, Tanios MA. Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacother, 2005; 25(10):1348-1352.
32. MacLaren R, Wachsman BA, Swift DK, et al. Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature. Pharmacotherapy, 1997; 17:1331-1337.
33. Chambrier C, Leclercq M, Saudin F, et al. Is vitamin K1 supplementation necessary in long-term parenteral nutrition? J Parent Enteral Nutr, 1998;22:87-90.
34. Lennon C, Davidson KW, Sadowski JA, et al. The vitamin K content of intravenous lipid emulsions. J Parent Enteral Nutr, 1993; 17:142-144.
35. Duerksen DR, Papineau N. Prevalence of coagulation abnormalities in hospitalized patients receiving lipid-based parenteral nutrition. J Parent Enteral Nutr, 2004;28(1):30-33.
36. Matarese LE. Metabolic Complications of Parenteral Nutrition Therapy. In: Gottschlich MM, Ed. The Science of Practice of Nutrition Support: A Case-Based Core Curriculum. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:275.
37. Faber MD, Schmidt RJ, Bear RA, et al. Management of fluid, electrolyte, and acid-base disorders in surgical patients. In: Narins RG (ed). Clinical Disorders of Fluid and Electrolyte Metabolism. 5th ed. New York: McGraw-Hill; 1987:1424.
38. Grant JP. Handbook of Total Parenteral Nutrition. 2nd ed. WB Saunders; Philadelphia, PA; 1992:174.
39. Parenteral multivitamin products; drugs for human use; drug efficacy study implementation: amended (21 CFR 5.70). Federal Register, 2000;65:21200-21201.
40. Boosalis MG. Micronutrients. In: Gottschlich MM. Ed. The Science and Practice of Nutritional Support: A Case Based Core-Curriculum. Dubuque. IA: Kendall/Hunt Publishing Co. 2001:94.
41. Helphingstine CJ, Bistrian BR. New food and drug administration requirements for inclusion of vitamin K in adult parenteral nutrition. J Parent Enteral Nutr, 2003;27(3):220-224.
42. Nutescu EA, Shapiro NL, Ibrahim S, et al. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Drug Saf, 2006;5(3):433-451.
43. Safe Practices for Parenteral Nutrition Formulations. National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition. J Parenter Enteral Nutr, 1998;22(2):49-66.
44. Btaiche IF, Khalidi N. Metabolic complications of parenteral nutrition in adults, part 2. Am J Health-Syst Pharm, 2004;61: 2050-2057.
45. Wardle CA, Forbes A, Roberts NB. et al. Hypermanganesemia in long-term intravenous nutrition and chronic liver disease. J Parenter Enteral Nutr, 2004;28:S39-S70.
46. Fessler TA. Trace Element Monitoring and Therapy For Adult Patients Receiving Long Term Total Parenteral Nutrition. Pract Gastroenterol, 2005;29(3):44.
47. Jeejeebhoy KN. Management of PN-induced Cholestasis. Pract Gastroenterol, 2005;29(2):62.
48. Sacks G. Drug-nutrient considerations in patients receiving parenteral and enteral nutrition. Pract Gastroenterol, 2004; 28(7):39.
49. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med, 2001;345:1359-1367.
50. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care, 1990;13(6):610-630.
51. Frothingham R. Glucose homeostasis abnormalities associated with use of gatifloxicin. Clin Infect Dis, 2005;41(9):1269-1276.
52. Stausburg KM. Drug interactions in nutrition support. In: McCabe JM, Frankel EH, Wolfe JJ, ed. Handbook of Food-Drug Interactions. Boca Raton, Fl: CRC Press; 2003: 145-166.
53. Montoro JB, Pou L, Salvador P, et al. Stability of famotidine 20 and 40 mg/L in total nutrient admixtures. Am J Hosp Pharm, 1989;46(11):2329-2332.
54. Hatton J, Luer M, Hirsch J, et al. Histamine receptor antagonists and lipid stability in total nutrient admixtures. J Parenter Enteral Nutr, 1994;18(4):308-312.
55. Product information: Ranitidine package insert, Bedford Laboratories, May 20.
56. Khaodhiar L, Keane-Ellison M, Tawa NE, et al. Iron deficiency anemia in patients receiving home total parenteral nutrition. J Parenter Enteral Nutr, 2002;26:114-119.
57. Kwong KW, Tsallas G. Dilute iron dextran formulation for addition to parenteral nutrient solutions. Am J Hosp Pharm, 1980; 37(2):206-210.
58. Vaughan LM, Small C, Plunkett V. Incompatibility of iron dextran and a total nutrient admixture. Am J Hop Pharm, 1990; 47:1745-1746.
59. Eisenberg PG, Gianino S, Clutter WE, et al. Abrupt discontinuation of cycled parenteral nutrition is safe. Dis Colon Rectum, 1995;38(9):933-939.
60. Krzywda EA, Andris DA, Whipple JK, et al. Glucose response to abrupt initiation and discontinuation of total parenteral nutrition. J Parent Enteral Nutr, 1993;17:64-67.
61. Nirula R, Yamada K, Waxman K. The effect of abrupt cessation of total parenteral nutrition on serum glucose: a randomized trial. Am Surg, 2000;66(9):866-869.
62. McCray S, Walker S, Parrish CR. Much ado about refeeding. Pract Gastroenterol, 2005;23:26-44.
63. Plank LD, Connolly AB, Hill GL. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg, 1998;228(2):146-158.
64. Klein CJ, Stanek GS, Wiles CE. Overfeeding macronutrients to critically ill adults: metabolic complications. J Am Diet Assoc, 1998;98(7):795-806.
65. Bu JA, Klish WJ, Walding WJ, et al. Energy metabolism, nitrogen balance, and substrate utilization in critically ill children. Am J Clin Nutr, 2001;74(5):664-669.
66. McClave SA, McClain CJ, Snider HL. Should indirect Calorimetry be used as a part of nutritional assessment? J Clin Gastroenterol, 2001;33(1):14-19.
67. Piazza-Barnett R, Matarese LE. Electrolyte management in total parenteral nutrition. Support Line, 1999;21(2):8-15.
68. Kraft MD, Btaiche IF, Sacks GS, et al. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health-Syst Pharm, 2005;62:1663-1682.